Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,836 public trials 1,783 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

NCT05159778

Conditions
Breast Diseases, Breast Neoplasms, Malignant Neoplasm of Breast, +4 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Colorado at Denver Denver, Colorado, United States
  • University of Miami and Clinics -Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Completed

Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer

NCT01269346

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Florida Cancer Care Davie, Florida, United States
  • Florida Oncology Associates Jacksonville, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 26 locations
View Trial Details
Completed

A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer

NCT01268150

Conditions
Breast Diseases, Breast Neoplasms, Locally Recurrent, +5 more
Locations
  • University of Miami Miami, Florida, United States
  • Augusta Oncology Associates Augusta, Georgia, United States
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States
View all 17 locations
View Trial Details
Completed

A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer

NCT00879086

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Northern AZ Hematology and Oncology Associates Sedona, Arizona, United States
  • Healing Hands Oncology and Medical Care Hawthorne, California, United States
  • University of Southern California Los Angeles, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
View all 50 locations
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

NCT00303914

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • John H. Stroger, Jr. Hospital of Cook County Chicago, Illinois, United States
  • Evanston Hospital Evanston, Illinois, United States
  • Elkhart General Hospital Elkhart, Indiana, United States
View all 32 locations
View Trial Details

Related conditions